Skip to main content

Wrongful Death Lawsuit Linked to J&J’s Talcum Powder

Wrongful Death Lawsuit Linked to J&J’s Talcum Powder

Wrongful Death Lawsuit Linked to J&J’s Talcum Powder

Introduction

A wrongful death lawsuit was filed in the U.S. District Court for the District of Rhode Island recently against Johnson & Johnson, Imerys Talc America, and Personal Care Products Council by a man on behalf of himself and his late wife. The man alleges that his late wife developed ovarian cancer linked to J&J’s Talcum Powder products’ use over 15 years and succumbed to it. Allegations include that the defendants had the knowledge of the increased risk of ovarian cancer associated with genital use of talc-based body powder, yet they continued to actively market the safety of the product to users and failed to inform customers and end-users of the products' health hazards, particularly when used by women in the perineal area.

The giant conglomerate J&J maintains that it does not intend to offer talcum powder settlements for women diagnosed with ovarian cancer. J&J is defending nearly 7,000 Talcum Powder lawsuits nationwide, filed by women who claim they developed ovarian cancer due to the long-term use of products promoted for feminine hygiene by the defendants. The motley of lawsuits is filed under MDL No. 2738- In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation formed in 2016, presided by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J., in the U.S. District Court for the District of New Jersey; hundreds of lawsuits are also filed in Missouri 22nd Circuit Court, St. Louis; cases are also filed in California and Delaware state courts.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!